Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06981546

Modeling Clinical Outcomes in Gambling Addiction

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
268 (estimated)
Sponsor
Hospices Civils de Lyon · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Gambling disorder (GD) is recognized as an addictive disorder. Financial consequences of GD are often dramatic, inducing professional, familial, legal and medical repercussions and particularly mental health consequences. MOGADOR is a longitudinal, multicentric, prospective, prognostic study, which aims to identify factors predicting the evolution of french patients with GD in care centers particularly involved in the management of GD. The main goal will focus on evolution of DSM-5 (Diagnostic and Statistical Manual of Mental Disorder 5th edition) GD criteria during the first year of follow-up. The prognostic factors will be collected at base-line and they will be considered to influence the long-term prognosis of patients. For patients suffering of GD, our main hypothesis is that initial factors like individual socio-demographic characteristics, clinical psychiatric profiles, addiction comorbidities, and behaviour are associated with the clinical prognosis (total remission of DSM-5 criteria of GD at 12 months). MOGADOR will be the first study, aiming to model prognostic aspects of GB in populations specially monitored for this disorder.

Conditions

Timeline

Start date
2025-09-01
Primary completion
2029-09-01
Completion
2030-09-01
First posted
2025-05-20
Last updated
2025-05-20

Locations

9 sites across 1 country: France

Source: ClinicalTrials.gov record NCT06981546. Inclusion in this directory is not an endorsement.

Modeling Clinical Outcomes in Gambling Addiction (NCT06981546) · Clinical Trials Directory